Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 209-216

  Morato, Manuela ^a,b   Pinho, Dora ^a   Sousa, Teresa ^a   Guimarães, Serafim ^a   Moura, Daniel ^a   Albino Teixeira, António ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Adenosine receptor blockade; Angiotensin II; Hypertension

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ADENOSINE RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SYMPATHETIC NERVE; VASOCONSTRICTION; VENOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HYPERTENSION; MALE; MESENTERIC ARTERIES; MESENTERIC VEINS; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; XANTHINES;

EID: 32044443594     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.009     Document Type: Article

References (50)

1. A. Albino-Teixeira, A. Matias, J. Polónia, and I. Azevedo Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat J. Hypertens. Suppl. 9 1991 S196 S197
2. J.C. Balt, M.-J. Mathy, M. Pfaffendorf, and P.A. van Zwieten Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan J. Hypertens. 19 2001 2241 2250
3. J.C. Balt, M.-J. Mathy, A. Nap, M. Pfaffendorf, and P.A. van Zwieten Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery J. Cardiovasc. Pharmacol. 40 2002 50 57
4. J.C. Balt, M.-J. Mathy, A. Nap, M. Pfaffendorf, and P.A. van Zwieten Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission J. Renin Angiotensin Aldosterone Syst. 3 2003 181 187
5. 1-receptor mediated increase of noradrenaline release by angiotensin II is seen only in the presence of prejunctional autoinhibition Adv. Exp. Med. Biol. 377 1995 293 298
6. L.A. Cassis, R.E. Stitzel, and R.J. Head Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms J. Pharmacol. Exp. Ther. 234 1985 792 803
7. M.G. Collis, and B.J. Alps Vascular reactivity to noradrenaline, potassium chloride, and angiotensin II in the rat perfused mesenteric vasculature preparation, during the development of renal hypertension Cardiovasc. Res. 9 1975 118 126
8. S.L. Cox, A. Ben, D.F. Story, and J. Ziogas Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites Br. J. Pharmacol. 114 1995 1057 1063
9. S.L. Cox, D.F. Story, and J. Ziogas Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat Br. J. Pharmacol. 119 1996 976 984
10. i/o protein-coupled receptors Br. J. Pharmacol. 129 2000 1095 1102
11. J.W. Daly, W. Padgett, M.T. Shamim, P. Butts-Lamb, and J. Waters 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for Ai- and A2-adenosine receptors J. Med. Chem. 28 1985 487 492
12. J. De Champlain Pre- and postsynaptic adrenergic dysfunctions in hypertension J. Hypertens. Suppl. 8 1990 S77 S85
13. D.C. Eikenburg, R.D. Ekas Jr., and M.F. Lokhanwala Strain differences in the facilitatory action of angiotensin on noradrenergic transmission in the rat mesentery Clin. Exp. Hypertens. 3 1981 1039 1051
14. D.C. Eikenburg, R.D. Ekas, and M.F. Lokhanwala Alterations in prejunctional responsiveness to angiotensin II during the development of 2-kidney, 1-clip Goldblatt hypertension in rats J. Pharmacol. Exp.Ther. 223 1982 766 773
15. R.D. Ekas Jr., and M.F. Lokhanwala Sympathetic nerve function and vascular reactivity in spontaneously hypertensive rats Am. J. Physiol. 241 1981 R379 R384
16. M.A. Enero, and B.Q. Saidman Possible feedback inhibition of noradrenaline release by purine compounds Naunyn-Schmiedeberg's Arch. Pharmacol. 297 1977 39 46
17. M. Esler, G. Jackman, A. Bobik, P. Leonard, D. Kelleher, H. Skews, G. Jennings, and P. Korner Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients Hypertension 3 1981 149 156
18. M.P. Galloway, and T.C. Westfall The release of endogenous norepinephrine from the coccygeal artery of spontaneously hypertensive and Wistar-Kyoto rats Circ. Res. 51 1982 225 232
19. S. Guimarães, and W. Osswald Adrenergic receptors in the veins of the dog Eur. J. Pharmacol. 5 1969 133 140
20. 1-purinoceptors J. Auton. Pharm. 16 1996 367 370
21. 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level Naunyn-Schmiedeberg's Arch. Pharmacol. 350 1994 692 695
22. S. Guimarães, A. Albino-Teixeira, and M.Q. Paiva Hypertension and enhanced β-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors Br. J. Pharmacol. 114 1995 1595 1598
23. S. Guimarães, M.Q. Paiva, and D. Moura Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries Br. J. Pharmacol. 124 1998 1207 1212
24. S. Guimarães, H. Pinheiro, P. Tavares, A. Loio, and D. Moura Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 363 2001 509 514
25. N. Iwai, and T. Inagami Identification of two subtypes in the rat type I angiotensin II receptor FEBS Lett. 298 1992 257 260
26. E.K. Jackson Adenosine: a physiological brake on renin release Annu. Rev. Pharmacol. Toxicol. 31 1991 1 35
27. 2-adrenoceptors and angiotensin II receptors in genetic hypertension Hypertension 38 2001 353 360
28. P. Karoon, A. Rubino, and G. Burnstock Enhanced sympathetic neurotransmission in the tail artery of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX)-treated rats Br. J. Pharmacol. 116 1995 1918 1922
29. H. Kawasaki, W.H. Cline, and C. Su Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats J. Pharmacol. Exp. Ther. 221 1982 112 116
30. P.A. Khairallah Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake Fed. Proc. 31 1972 1351 1357
31. 3H](norepinephrine release from perfused mesenteric arteries of SHR and renal hypertensive rats Eur. J. Pharmacol. 87 1983 349 352
32. L.T. Lais, and M.J. Brody Vasoconstrictor hyperresponsiveness: an early pathogenic mechanism in the spontaneously hypertensive rat Eur. J. Pharmacol. 47 1978 177 189
33. J.W. McCubbin, R.S. DeMoura, I.H. Page, and F. Olmsted Arterial hypertension elicited by subpressor amounts of angiotensin Science 149 1965 1394 1395
34. M. Morato, T. Sousa, S. Guimarães, D. Moura, and A. Albino-Teixeira The role of angiotensin II in hypertension due to adenosine receptors blockade Eur. J. Pharmacol. 455 2002 135 141
35. M. Morato, T. Sousa, S. Guimarães, D. Moura, and A. Albino-Teixeira Losartan and atenolol on hypertension induced by adenosine receptor blockade Auton. Autacoid Pharmacol. 23 2003 133 140
36. 2- autoreceptors and receptors mediating the effects of angiotensin II and bradykinin in the heart of newborn rats Eur. J. Pharmacol. 453 2002 265 270
37. 2- autoreceptor stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release Naunyn-Schmiedeberg's Arch. Pharmacol. 368 2003 443 447
38. D. Moura, H. Pinheiro, M.Q. Paiva, and S. Guimarães Prejunctional effects of angiotensin II and bradykinin in the heart and blood vessels J. Auton. Pharm. 19 1999 321 325
39. 1B receptors J. Cardiovasc. Pharmacol. 43 2004 14 20
40. E.H. Ohlstein, D.P. Brooks, G.Z. Feuerstein, and R.R. Ruffolo Jr. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade Pharmacology 55 1997 244 251
41. M.G. Persson, A. Öhlén, L. Lindbom, P. Hedqvist, and L.E. Gustafsson Role of adenosine in functional hyperemia in skeletal muscle as indicated by pharmacological tools Naunyn-Schmiedeberg's Arch. Pharmacol. 343 1991 52 57
42. 1 angiotensin II antagonists at pre- and postjunctional angiotensin II receptors of the rat tail artery Naunyn-Schmiedeberg's Arch. Pharmacol. 366 2002 537 542
43. 1-purinoceptor antagonist, DPSPX Br. J. Pharmacol. 118 1996 1675 1680
44. A. Rubino, and G. Burnstock Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8- sulfophenylxanthine-induced hypertension J. Pharmacol. Exp. Ther. 275 1995 422 428
45. P. Soares-da-Silva, M. Pestana, M.A. Vieira-Coelho, M.H. Fernandes, and A. Albino-Teixeira Assessment of renal dopaminergic activity during long-term nitric oxid synthase inhibition Br. J. Pharmacol. 114 1995 1403 1413
46. T. Sousa, M. Morato, and A. Albino-Teixeira Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors Eur. J. Pharmacol. 441 2002 99 104
47. K. Starke, and H.J. Schumann Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulation Eur. J. Pharmacol. 18 1972 27 30
48. E.J. Sybertz, and M.J. Peach In vitro neurogenic and musculotropic responses to angiotensin peptides in normal and sodium-restricted rabbits Circ. Res. 46 1980 836 842
49. S.P. Tofovic, K.R. Branch, R.D. Oliver, W.D. Magee, and E.K. Jackson Caffeine potentiates vasodilator-induced renin release J. Pharmacol. Exp. Ther. 256 1991 850 860
50. B.G. Zimmerman, S.K. Gomer, and J.C. Liao Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release Fed. Proc. 31 1972 1344 1350